Literature DB >> 6537406

Management of status epilepticus--a review.

K Venkataswarlu, S Mehta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537406     DOI: 10.1007/bf02776387

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  13 in total

1.  Status epilepticus; history, incidence and problems.

Authors:  R A HUNTER
Journal:  Epilepsia       Date:  1959-12       Impact factor: 5.864

2.  The earliest alterations in rat neurones and astrocytes after anoxia-ischaemia.

Authors:  A W Brown; J B Brierley
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

3.  The critically ill child: management of status epilepticus.

Authors:  S Carter; A P Gold
Journal:  Pediatrics       Date:  1969-11       Impact factor: 7.124

4.  Status epilepticus and diazepam.

Authors:  D S Bell
Journal:  Br Med J       Date:  1969-03-15

5.  Current concepts in neurology: management of status epilepticus.

Authors:  A V Delgado-Escueta; C Wasterlain; D M Treiman; R J Porter
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

6.  Letter: Treatment of status epilepticus with sodium valproate.

Authors:  A R Manhire; M Espir
Journal:  Br Med J       Date:  1974-09-28

7.  Free fatty acids in the brain in bicuculline-induced status epilepticus.

Authors:  A Chapman; M Ingvar; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1980-11

8.  Rectal administration of sodium valproate in status epilepticus.

Authors:  F J Vajda; G W Mihaly; J L Miles; G A Donnan; P F Bladin
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

9.  Convulsive status epilepticus in infants and children. A study of 239 cases.

Authors:  J Aicardi; J J Chevrie
Journal:  Epilepsia       Date:  1970-06       Impact factor: 5.864

10.  Lorazepam in status epilepticus.

Authors:  J E Walker; R W Homan; M R Vasko; I L Crawford; R D Bell; W G Tasker
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.